Top compounds associated with response to KCTD4


Feature Type Standardized
Nominal ANOVA
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.097 0.01
mRNA MK 1775 CTRPv2 pan-cancer AAC -0.092 0.02
mRNA BIRB 0796 GDSC1000 pan-cancer AAC -0.088 0.02
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.087 0.02
mRNA ciclopirox CTRPv2 pan-cancer AAC -0.087 0.02
mRNA Gemcitabine CTRPv2 pan-cancer AAC -0.086 0.02
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.084 0.02
mRNA piperlongumine CTRPv2 pan-cancer AAC -0.083 0.02
mRNA Sunitinib GDSC1000 pan-cancer AAC -0.12 0.02
mRNA CR-1-31B CTRPv2 pan-cancer AAC -0.083 0.02
Download CSV